People · Operator
Named in public records as an officer, director or promoter · active 2013–2013 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cingulate Therapeutics | — | Pharmaceuticals | Series B | $33.0M | $890.9M | 2013 |
Louis George Van Horn at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Louis George Van Horn on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Patrick J. Gallagher | 1 | 4 |
| Peter J. Werth | 1 | 3 |
| Jeff J Hargroves | 1 | 2 |
| Shane J Schaffer | 1 | 2 |
| Jeff J Conroy | 1 | 2 |
| Arthur B Straughn | 1 | 1 |
| Craig Stephen Tashjy | 1 | 1 |
| Matthew N Brams | 1 | 1 |
| Craig Steven Gilgallon | 1 | 1 |
| Laurie A Myers | 1 | 1 |
| Raul R Silva | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.